Keywords: repligen, starts, pivotal, autism, trial, started, its

Repligen starts pivotal autism trial

Article | 25 February 2002

Repligen has started its first Phase III trials of secretin in pediatricpatients with autism, after reporting positive new clinical results ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in